Hisamitsu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HISAMITSU, and what generic alternatives to HISAMITSU drugs are available?
HISAMITSU has two approved drugs.
There are seven US patents protecting HISAMITSU drugs.
There are fifty-four patent family members on HISAMITSU drugs in eighteen countries and three supplementary protection certificates in three countries.
Summary for Hisamitsu
| International Patents: | 54 |
| US Patents: | 7 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Patent Litigation for Hisamitsu: | See patent lawsuits for Hisamitsu |
Drugs and US Patents for Hisamitsu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-001 | Oct 11, 2019 | RX | Yes | Yes | 9,687,474 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-003 | Oct 11, 2019 | RX | Yes | No | 10,814,002 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-001 | Feb 20, 2008 | OTC | Yes | Yes | 8,809,615 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-001 | Oct 11, 2019 | RX | Yes | Yes | 10,583,121 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-001 | Oct 11, 2019 | RX | Yes | Yes | 11,123,305 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-002 | Oct 11, 2019 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Hisamitsu Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 102013477 | See Plans and Pricing |
| Japan | WO2014017594 | See Plans and Pricing |
| China | 104487072 | See Plans and Pricing |
| Taiwan | 201410272 | See Plans and Pricing |
| Japan | 2017025111 | See Plans and Pricing |
| Poland | 2878300 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hisamitsu Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0746317 | SPC/GB10/046 | United Kingdom | See Plans and Pricing | PRODUCT NAME: ASENAPINE; REGISTERED: UK EU/1/10/640/001 20100901; UK EU/1/10/640/002 20100901; UK EU/1/10/640/003 20100901; UK EU/1/10/640/004 20100901; UK EU/1/10/640/005 20100901; UK EU/1/10/640/006 20100901 |
| 0746317 | C300461 | Netherlands | See Plans and Pricing | PRODUCT NAME: ASENAPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET MALEAAT; REGISTRATION NO/DATE: EU/1/10/640/001-006 20100901 |
| 0746317 | 10C0056 | France | See Plans and Pricing | PRODUCT NAME: ASENAPINE; REGISTRATION NO/DATE: EU/1/10/640/001 20100901 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
